Clik here to view.
TB Alliance and Takeda Announce Advancement of Joint Program Investigating...
NEW YORK & OSAKA, Japan The Global Alliance for TB Drug Development (Headquarters: New York, USA, “TB Alliance”) and Takeda Pharmaceutical Company Limited (Headquarters: Osaka, Japan; “Takeda”)...
View ArticleClik here to view.
TB联盟与武田宣布通过全球健康创新技术基金推动有望作为新型结核病治疗药物的化合物的联合研究项目
纽约和日本大阪 (美国商业资讯) — 全球结核病药物研发联盟（总部：美国纽约，简称“TB联盟”）与武田药品工业株式会社（总部：日本大阪；简称“武田”）宣布，双方已签署一份协议，以进一步探索一个高通量筛选项目产出的筛出物，该项目旨在寻找改善结核病(TB)治疗的新型化合物。这一联合研究项目由全球健康创新技术(GHIT)基金资助，设立该基金旨在促进研发传染病所需的药品、疫苗和诊断试剂。 Smart...
View ArticleClik here to view.
昆泰“解决方案设计工作室”揭幕
Smart Multimedia Gallery ビデオタイトル QuickTimeで再生 WindowsMediaで再生 北卡罗莱纳州研究三角园区 (美国商业资讯) — 世界最大的产品开发和整合医疗保健服务提供商昆泰已启用其全球“解决方案设计工作室”(Solution Design Studio)，专家团队将在这里合作打造应对医疗保健业某些最大挑战的技术解决方案。 Smart News...
View ArticleClik here to view.
クインタイルズがソリューション・デザイン・スタジオを開設
Smart Multimedia Gallery ビデオタイトル QuickTimeで再生 WindowsMediaで再生 米ノースカロライナ州リサーチ・トライアングル・パーク （ビジネスワイヤ） —...
View ArticleClik here to view.
LCT’s NTCELL® Parkinson’s Trial Results to Be Presented in Berlin
SYDNEY & AUCKLAND, New Zealand As advised in our 7 June announcement of the trial results, Dr Barry Snow is presenting 81 week+ data on the safely and clinical effects of NTCELL in patients with...
View ArticleClik here to view.
Sosei Appoints Peter Bains as CEO
TOKYO Sosei Group Corporation (“Sosei”; TOKYO Mothers Index: 4565) today announces the appointment of Mr Peter Bains as Representative Executive Officer and Chief Executive Officer (CEO) effective...
View ArticleClik here to view.
Q2 Solutions获得礼来公司2016年度全球供应商奖
北卡罗莱纳州莫里斯维尔 (美国商业资讯)–全球性临床试验实验室服务组织Q2 Solutions今天宣布，该公司已获得2016年度礼来全球供应商奖。Q2 Solutions是今年获奖的12家公司之一，该奖项表彰该公司对礼来药物开发工作的持续贡献。 Smart News Releases（智能新闻稿）是一个多媒体平台。在此处查看完整新闻稿：...
View ArticleClik here to view.
Cytori Cell Therapy Receives Limited Approval for Osteoarthritis in Japan
SAN DIEGO & TOKYO Cytori Therapeutics, Inc. (NASDAQ: CYTX) today announced that the use of Cytori Cell Therapy™ was approved for clinical use on June 24th, 2016 to treat knee osteoarthritis at...
View ArticleClik here to view.
Q2ソリューションズがイーライリリー・アンド・カンパニーから2016年グローバル・サプライヤー賞を受賞
米ノースカロライナ州モリスビル （ビジネスワイヤ） — 世界的な臨床試験ラボサービス組織のQ2ソリューションズは本日、2016年リリー・グローバル・サプライヤー賞を受賞したと発表しました。Q2ソリューションズは、リリーの医薬品開発活動に対する継続的な貢献が評価され、今年この賞を受賞した12社の1つに選ばれました。 このSmart News...
View ArticleClik here to view.
Clik here to view.
BioLegend与Sanquin签署 多肽-MHC检测技术授权协议
圣迭戈 (美国商业资讯) — BioLegend宣布，Sanquin血液制品供应基金会已向其授权了一项研究抗原特异性T细胞的新型技术。位于阿姆斯特丹的Sanquin试剂部门和荷兰癌症研究所 (NKI)...
View ArticleClik here to view.
Osstem Implant Selects Dassault Systèmes’ “License to Cure for Medical...
VELIZY-VILLACOUBLAY, France Dassault Systèmes (Euronext Paris: #13065, DSY.PA) (Paris:DSY), the 3DEXPERIENCE Company, world leader in 3D design software, 3D Digital Mock Up and Product Lifecycle...
View ArticleClik here to view.
Recent Settlement in Promega/Genovis Case Maintains Continued Offering of...
MADISON, Wis. A recent settlement between Promega Corporation and Genovis AB maintains full freedom for the continued offering of Promega’s IdeS and IdeZ Proteases for markets worldwide. In November...
View ArticleClik here to view.
Poxel Announces Patient Enrollment Completed for Imeglimin Phase 2b Clinical...
LYON, France POXEL SA (Euronext – POXEL – FR0012432516), a biopharmaceutical company focused on the development of innovative drugs to treat type 2 diabetes, today announced that it has completed...
View ArticleClik here to view.
BATM’s Adaltis to Receive Investment and Enters into Strategic Joint Venture...
HOD HASHARON, Israel BATM Advanced Communications Limited (LSE: BVC) (“BATM” or “the Group”), a leading provider of real-time technologies for networking solutions and medical laboratory systems, is...
View ArticleClik here to view.
Ligand Receives $4 Million from Expansion of Two OmniAb® License Agreements
SAN DIEGO Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces that two recent events relating to its OmniAb platform generated $4 million in combined payments due to Ligand. One event...
View ArticleClik here to view.
Takeda to Partner with Altos Therapeutics to Develop Promising Compound for...
OSAKA, Japan & LOS ALTOS, Calif. Takeda Pharmaceutical Company Limited (TSE: 4502) and Altos Therapeutics LLC today jointly announced the companies have entered into a definitive agreement to...
View ArticleClik here to view.
武田薬品とAltos Therapeuticsによる胃不全麻痺治療薬の開発に関する提携について
大阪 & 米カリフォルニア州ロスアルトス （ビジネスワイヤ） — 武田薬品工業株式会社（本社：大阪市中央区、以下「武田薬品」）とAltos Therapeutics...
View ArticleClik here to view.
Takeda to Partner with Altos Therapeutics to Develop Promising Compound for...
OSAKA, Japan & LOS ALTOS, Calif. Takeda Pharmaceutical Company Limited (TOKYO:4502) and Altos Therapeutics LLC today jointly announced the companies have entered into a definitive agreement to...
View ArticleClik here to view.
武田与Altos Therapeutics合作开发有望用于治疗胃轻瘫的化合物
日本大阪和加州洛思阿图斯 (美国商业资讯) — 武田药品工业株式会社(TOKYO:4502)与Altos Therapeutics...
View Article